Get informed when a big investor buys or sells
+ FollowOctober 22, 2026 - AI Summary
Overvalued by 150.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.08 Billion |
|---|---|
| Enterprise Value | $1.59 Billion |
| Earnings per Share | $2.16 |
| Beta | 0.49 |
| Outstanding Shares | 65,352,000 |
| P/E Ratio | 77.77 |
|---|---|
| PEG | 46.39 |
| Price to Sales | 1.52 |
| Price to Book Ratio | 2.12 |
| Enterprise Value to Revenue | 1.13 |
| Enterprise Value to EBIT | 4.41 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Bonesupport Holding AB (publ) operates as a prominent orthobiologics firm, dedicated to the development and worldwide commercialization of injectable bioceramic bone graft alternatives. These solutions are utilized for filling bone voids...